# 药销通

> 药销通 (iPhone/iPad app by Shandong ZiLue Information Technology Co.,Ltd..)

- Source: https://appshunter.io/ios/app/id1362578246 (this page in markdown: same URL + `.md`)
- Developer: [Shandong ZiLue Information Technology Co.,Ltd.](https://appshunter.io/developer/1080088186)
- Category: Medical, Utilities
- Price: Free
- Age rating: 17+
- Requires: iOS 15.0 · 96 MB
- Languages: Chinese (Simplified, China)
- Released: 2018-03-30
- Data updated: 2026-08-29
- User reviews in markdown: https://appshunter.io/ios/app/id1362578246/reviews.md

## What is 药销通?

药销通平台协助药企、营销团队、代理服务商实现“管理精细化、业务合规化、费控全程化、管理效能化”， 提供了基础信息管理、CRM客户资源管理、合作关系管理、营销数据管理、外包服务过程管理、服务费控管理、团队效能和决策分析等功能， 协助我们更迅速的业务转型和可持续的阳光合作！


## Version history (last 5 releases)

### 3.0.13 — 2026-08-20

修复已知问题，优化系统稳定性

### 3.0.12 — 2026-06-24

修复已知问题，优化系统稳定性

### 3.0.11 — 2026-03-21

修复已知问题，优化系统稳定性

### 3.0.10 — 2026-02-10

修复已知问题，优化系统稳定性

### 3.0.9 — 2026-01-29

修复已知问题，优化系统稳定性

## Apps similar to 药销通

| App | Rating | Price | Category |
| --- | --- | --- | --- |
| [环球医药网](https://appshunter.io/ios/app/id1291851894) | — | Free | Medical |
| [药智数据-医药掌上数据库](https://appshunter.io/ios/app/id1025304074) | 4.3 (6) | Free | Medical |
| [药脉通Pro](https://appshunter.io/ios/app/pro/id1585936485) | — | Free | Medical |
| [金草医生](https://appshunter.io/ios/app/id1329899812) | — | Free | Medical |
| [药脉通 - 400万药械人在这里找机会](https://appshunter.io/ios/app/400/id1071385064) | — | Free | Medical |
| [药源网](https://appshunter.io/ios/app/id1460076442) | — | Free | Medical |

## More apps by Shandong ZiLue Information Technology Co.,Ltd.

- [药代通](https://appshunter.io/ios/app/id1080088187)
- [药代通极速版](https://appshunter.io/ios/app/id1563162893)
- [药销通私有版](https://appshunter.io/ios/app/id1586451906)
- [蜂巢众包](https://appshunter.io/ios/app/id6444599523)

All apps by Shandong ZiLue Information Technology Co.,Ltd.: https://appshunter.io/developer/1080088186

---

*Data collected daily from the US App Store and indexed by [AppsHunter](https://appshunter.io/). User reviews are verbatim App Store reviews. Ratings, prices and chart positions refresh continuously; this snapshot is from 2026-08-29.*